BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34643271)

  • 1. The use of intralesional corticosteroid combined with narrowband ultraviolet B in vitiligo treatment: clinical, histopathologic, and histometric evaluation.
    El-Domyati M; Anbar TS; Yehia M; Abdel-Aziz RTA
    Int J Dermatol; 2022 May; 61(5):582-590. PubMed ID: 34643271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narrowband ultraviolet B phototherapy combined with intralesional injection of either latanoprost or platelet-rich plasma for stable nonsegmental vitiligo.
    Fawzy M; Al-Mokadem S; Alshereef M; Elkholy B
    Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12929. PubMed ID: 37984828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT.
    Batchelor JM; Thomas KS; Akram P; Azad J; Bewley A; Chalmers JR; Cheung ST; Duley L; Eleftheriadou V; Ellis R; Ferguson A; Goulding JM; Haines RH; Hamad H; Ingram JR; Laguda B; Leighton P; Levell N; Makrygeorgou A; Meakin GD; Millington A; Ogboli M; Rajasekaran A; Ravenscroft JC; Rogers A; Sach TH; Santer M; Stainforth J; Tan W; Wahie S; White J; Whitton ME; Williams HC; Wright A; Montgomery AA
    Health Technol Assess; 2020 Nov; 24(64):1-128. PubMed ID: 33245043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
    Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
    J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo.
    Silpa-Archa N; Weerasubpong P; Junsuwan N; Yothachai P; Supapueng O; Wongpraparut C
    J Dermatolog Treat; 2019 Nov; 30(7):691-696. PubMed ID: 30474443
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas.
    Vachiramon V; Chaiyabutr C; Rattanaumpawan P; Kanokrungsee S
    Lasers Surg Med; 2016 Feb; 48(2):197-202. PubMed ID: 26175036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Band-pass Filter Cream (TBFC)-assisted home-based NB-UVB: A must-know Alternative to artificial phototherapy.
    Sonthalia S
    J Cosmet Dermatol; 2021 Jul; 20(7):2141-2147. PubMed ID: 33977652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of using fractional CO
    Ghasemloo S; Gauthier Y; Ghalamkarpour F
    J Dermatolog Treat; 2019 Nov; 30(7):697-700. PubMed ID: 30592235
    [No Abstract]   [Full Text] [Related]  

  • 9. Study the effect of erbium:YAG laser plus topical 5-flurouracil in stable vitiligo resistant to NB-UVB phototherapy.
    Doghaim NN; El-Tatawy RA; Ismail MA; Ali DAM; El Attar YA
    J Cosmet Dermatol; 2020 Jan; 19(1):122-130. PubMed ID: 31571367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
    Asawanonda P; Kijluakiat J; Korkij W; Sindhupak W
    Acta Derm Venereol; 2008; 88(4):376-81. PubMed ID: 18709309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NB-UVB plus oral Polypodium leucotomos extract display higher efficacy than NB-UVB alone in patients with vitiligo.
    Pacifico A; Damiani G; Iacovelli P; Conic RRZ; ; Gonzalez S; Morrone A
    Dermatol Ther; 2021 Mar; 34(2):e14776. PubMed ID: 33433041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: A prospective, randomized comparative trial.
    Abdelghani R; Ahmed NA; Darwish HM
    J Cosmet Dermatol; 2018 Jun; 17(3):365-372. PubMed ID: 28834191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of combined microneedling and narrowband ultraviolet B phototherapy versus their combination with topical latanoprost in the treatment of vitiligo.
    Neinaa YME; Lotfy SS; Ghaly NR; Doghaim NN
    Dermatol Ther; 2021 Mar; 34(2):e14813. PubMed ID: 33497514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple combination therapy of narrowband ultraviolet B, fractional carbon dioxide laser and topical bimatoprost 0.01% for non-segmental vitiligo on non-facial areas: A randomized half-body, double-blind, placebo-controlled, comparative study.
    Kanokrungsee S; Khunkhet S; Rojhirunsakool S; Thadvibun K; Sahaspot T
    Dermatol Ther; 2022 Jan; 35(1):e15198. PubMed ID: 34750933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy between localized 308-nm excimer light and targeted 311-nm narrowband ultraviolet B phototherapy in vitiligo: A randomized, single-blind comparison study.
    Poolsuwan P; Churee C; Pattamadilok B
    Photodermatol Photoimmunol Photomed; 2021 Mar; 37(2):123-130. PubMed ID: 33047405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo Trial.
    Thomas KS; Batchelor JM; Akram P; Chalmers JR; Haines RH; Meakin GD; Duley L; Ravenscroft JC; Rogers A; Sach TH; Santer M; Tan W; White J; Whitton ME; Williams HC; Cheung ST; Hamad H; Wright A; Ingram JR; Levell NJ; Goulding JMR; Makrygeorgou A; Bewley A; Ogboli M; Stainforth J; Ferguson A; Laguda B; Wahie S; Ellis R; Azad J; Rajasekaran A; Eleftheriadou V; Montgomery AA;
    Br J Dermatol; 2021 May; 184(5):828-839. PubMed ID: 33006767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
    Asawanonda P; Klahan SO
    Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effect of combined intralesional injection of prostaglandin F2α with narrow band UVB phototherapy in treatment of resistant cases of vitiligo.
    Eldelee SA; Gheida SF; Sarhan NI; Ibrahim ZA; Elfar NN
    J Dermatolog Treat; 2021 Jun; 32(4):383-390. PubMed ID: 31437059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of platelet-rich plasma on the outcome of short-term narrowband-ultraviolet B phototherapy in the treatment of vitiligo: a pilot study.
    Ibrahim ZA; El-Ashmawy AA; El-Tatawy RA; Sallam FA
    J Cosmet Dermatol; 2016 Jun; 15(2):108-16. PubMed ID: 26695436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of localized vitiligo with targeted broadband UVB phototherapy: a pilot study.
    Asawanonda P; Charoenlap M; Korkij W
    Photodermatol Photoimmunol Photomed; 2006 Jun; 22(3):133-6. PubMed ID: 16719866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.